NDC 71288-169
Cytarabine
Cytarabine
Cytarabine is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Cytarabine.
| Product ID | 71288-169_a1c0744e-94cf-4af1-9e10-0d1d50c77eaf |
| NDC | 71288-169 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cytarabine |
| Generic Name | Cytarabine |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2022-02-28 |
| Marketing Category | ANDA / |
| Application Number | ANDA208485 |
| Labeler Name | Meitheal Pharmaceuticals Inc. |
| Substance Name | CYTARABINE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |